BACKGROUND: Hyaluronic acid is generally accepted today as the "gold standard" filler agent, and its use has subsequently grown enormously. In addition, newer facial volume augmentation indications are constantly evolving. Rare adverse events, such as granulomas, have been described. However, complications are more commonly due to product misplacement or overcorrection leading to unsightly lumps and masses. Hyaluronidase treatment of these latter adverse effects can be both effective and rapid. OBJECTIVE: This paper aims to confirm the efficacy of hyaluronidase injections in dissolving unsightly hyaluronic acid overcorrection. METHODS: A case of hyaluronic acid overcorrection is described with evaluation of the effects of hyaluronidase. RESULTS: The use of hyaluronidase, injected intracutaneously permits the elimination of patient discomfort and inaesthetic lumps within a few hours. CONCLUSIONS: Hyaluronidase is highly effective in eliminating HA volume overcorrection.
No takes yet. Share an insight, caveat, or question.
André et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: